scholarly journals Medical Nutrition Therapy for Type-2 Diabetes

2019 ◽  
Vol 12 (4) ◽  
Author(s):  
Gulfam Ahmad Cheema
Keyword(s):  
Chronic Disease Management ◽  
Nutrition Therapy ◽  
Glycaemic Index ◽  
Lipid Lowering ◽  
Chronic Medical Conditions ◽  
Medical Nutrition Therapy ◽  
Soluble Fibre ◽  
Glycaemic Load ◽  
Medical Nutrition

Medical nutrition therapy remains the cornerstone in chronic disease management, apart from medication and regular physical activity. Various clinical practice guidelines and position papers from worldwide associations have incorporated specific nutrition recommendations in managing chronic diseases such as diabetes mellitus, hypertension, hyperlipidaemia, gout and chronic renal failure, which aim to prevent further complications or other co-morbidities arise from these chronic medical conditions. In addition, specific issues such as carbohydrate exchange, glycaemic index and glycaemic load for people with diabetes; DASH diet for hypertensive individuals, latest concerns on trans-fat, the usage of plant sterol and soluble fibre in enhancing lipid lowering will also be addressed in this article.

Medical Nutrition Therapy in the Treatment of Type 1 and Type 2 Diabetes

2009 ◽  
pp. 245-260
Author(s):  
Olga Kordonouri ◽  
Caroline Apovian ◽  
Lauren Kuhn ◽  
Thomas Danne ◽  
Christos S. Mantzoros
Keyword(s):  
Type 2 Diabetes ◽  
Nutrition Therapy ◽  
Medical Nutrition Therapy ◽  
Medical Nutrition

scholarly journals The role of celebrity diets versus medical nutrition therapy in type 2 diabetes

2015 ◽  
Vol 03 (01) ◽  
pp. 061-063
Author(s):  
Sandra Scrivens
Keyword(s):  
Type 2 Diabetes ◽  
Weight Loss ◽  
Nutrition Therapy ◽  
Overweight And Obesity ◽  
Medical Nutrition Therapy ◽  
Modest Weight Loss ◽  
The Individual ◽  
Medical Nutrition

AbstractWith global obesity affecting 475 million people worldwide, the continued popularity of celebrity or fad diets is not surprising. Evidence for their sustainability and long-term positive benefits on weight loss and cardiometabolic risk is, however, limited. Modest weight loss of 5-10% in overweight or obesity is associated with improvements in blood lipids, glycemia, and insulin resistance. As overweight and obesity are the main risk factors for Type 2 diabetes (T2DM), medical nutrition therapy based on a balanced, reduced total energy diet, tailored to the individual, is recommended by the American Diabetes Association, Diabetes UK and transcultural diabetes-specific nutrition algrorithm (tDNA) guidelines.

Medical Nutrition Therapy and Weight Loss Questions for the Evidence Analysis Library Prevention of Type 2 Diabetes Project: Systematic Reviews

2017 ◽  
Vol 117 (10) ◽  
pp. 1578-1611 ◽  
Author(s):  
Hollie A. Raynor ◽  
Patricia G. Davidson ◽  
Heather Burns ◽  
Micki D. Hall Nadelson ◽  
Shelley Mesznik ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Weight Loss ◽  
Systematic Reviews ◽  
Nutrition Therapy ◽  
Medical Nutrition Therapy ◽  
Evidence Analysis ◽  
Medical Nutrition

A Medical Nutrition Therapy Program Improves Perinatal Outcomes in Mexican Pregnant Women With Gestational Diabetes and Type 2 Diabetes Mellitus

2009 ◽  
Vol 35 (6) ◽  
pp. 1004-1013 ◽  
Author(s):  
Otilia Perichart-Perera ◽  
Margie Balas-Nakash ◽  
Adalberto Parra-Covarrubias ◽  
Ameyalli Rodriguez-Cano ◽  
Aurora Ramirez-Torres ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Gestational Diabetes ◽  
Perinatal Outcomes ◽  
Nutrition Therapy ◽  
Medical Nutrition Therapy ◽  
Therapy Program ◽  
Medical Nutrition

scholarly journals Efficacy of green jackfruit flour as a medical nutrition therapy replacing rice or wheat in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
A. Gopal Rao ◽  
K. Sunil Naik ◽  
A. G. Unnikrishnan ◽  
James Joseph
Keyword(s):  
Diabetes Mellitus ◽  
Nutrition Therapy ◽  
Controlled Study ◽  
Medical Nutrition Therapy ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Group A ◽  
Group B ◽  
Medical Nutrition

Abstract Background/Objectives Medical nutrition therapy along with pharmacological interventions as a multidisciplinary approach is required to treat type 2 diabetes mellitus (T2DM). This study evaluated the efficacy of Jackfruit365™ green jackfruit flour as an integral part of daily meal in patients with T2DM. Subjects/Methods This was a randomized, double-blind, placebo-controlled study conducted between May 2019 and February 2020. Patients of either sex aged ≥18 to ≤60 years with a diagnosis of T2DM for >1 year receiving oral antihyperglycemic agents were randomized (1:1) to receive either jackfruit flour 30 g/day (Group A) or placebo flour (Group B) (breakfast and dinner) daily for 12 weeks replacing an equal volume of rice or wheat flour. The primary endpoint was a mean change in glycosylated hemoglobin (HbA1c). Other endpoints were mean changes in fasting plasma glucose (FPG), postprandial plasma glucose (PPG), lipid profile, and body weight. The independent t-test was used to compare changes between the groups. Results A total of 40 patients were enrolled (n = 20 each). A significantly higher reduction in HbA1c was observed in Group A compared to Group B from baseline to week 12 [−2.73 mmol/mol (−0.25%) vs. 0.22 mmol/mol (0.02%), p = 0.006]. The mean change in FPG and PPG was significantly higher in Group A than that of Group B (p = 0.043 and p = 0.001). The continuous glucose monitoring showed decreasing mean blood glucose in 7 days of administration of jackfruit flour meal. Conclusion Patients from Group A had a significantly higher reduction in HbA1c, FPG, and PPG than Group B demonstrating the efficacy of jackfruit flour in glycemic control as medical nutrition therapy replacing an equal volume of rice or wheat flour in daily meal. Clinical trial registry CTRI/2019/05/019417.

Sign in / Sign up

Export Citation Format

Share Document